1. Home
  2. TOI vs NAGE Comparison

TOI vs NAGE Comparison

Compare TOI & NAGE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo The Oncology Institute Inc.

TOI

The Oncology Institute Inc.

HOLD

Current Price

$4.10

Market Cap

304.4M

Sector

Health Care

ML Signal

HOLD

Logo Niagen Bioscience Inc.

NAGE

Niagen Bioscience Inc.

HOLD

Current Price

$3.68

Market Cap

290.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TOI
NAGE
Founded
2007
1999
Country
United States
United States
Employees
641
117
Industry
Medical/Nursing Services
Medicinal Chemicals and Botanical Products
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
304.4M
290.7M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
TOI
NAGE
Price
$4.10
$3.68
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
3
Target Price
$6.67
$16.00
AVG Volume (30 Days)
1.4M
916.3K
Earning Date
05-07-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$30.15
$16.51
Revenue Next Year
$25.77
$14.58
P/E Ratio
N/A
$21.29
Revenue Growth
N/A
N/A
52 Week Low
$2.02
$3.60
52 Week High
$4.88
$14.66

Technical Indicators

Market Signals
Indicator
TOI
NAGE
Relative Strength Index (RSI) 63.16 30.33
Support Level $3.35 N/A
Resistance Level $4.15 $5.22
Average True Range (ATR) 0.25 0.21
MACD -0.01 -0.10
Stochastic Oscillator 70.31 5.59

Price Performance

Historical Comparison
TOI
NAGE

About TOI The Oncology Institute Inc.

The Oncology Institute Inc offers oncology care and treatment services to patients through several clinics located across the United States. It offers services such as infusion chemotherapy, oral drug chemotherapy, hospice and palliative care, autologous stem cell transplants, outpatient blood product transfusions, patient navigator programs, radiation oncology, and others on a fee or value-based model. Additionally, the company enrolls patients in clinical trials, where appropriate. The company has three operating segments: Specialty Pharmacy, Patient Services, and Clinical Trials and Other. Maximum revenue is generated from the Specialty Pharmacy segment, which operates specialty and retail pharmacies providing IV-infused, oral, injectable, and other medications for oncology treatment.

About NAGE Niagen Bioscience Inc.

Niagen Bioscience Inc is the leader in NAD+ (nicotinamide adenine dinucleotide) science and healthy-aging research. It is dedicated to advancing healthspan through precision science and innovative NAD+-boosting solutions. It is is clinically proven to increase NAD+ levels efficiently and effectively, and is the key ingredient powering our suite of Niagen brands.

Share on Social Networks: